0 Σχόλια
0 Μοιράστηκε
51 Views
0 Προεπισκόπηση
Προωθημένο
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
-
Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
Why the Human Rabies Vaccine Market Is Becoming a Critical Focus in Global Public Health and Disease PreventionRabies continues to be one of the most serious viral diseases, especially in regions where animal bites are common and healthcare access is limited. Despite being preventable, rabies still causes thousands of deaths annually across the globe. This has pushed governments and healthcare organizations to prioritize vaccination programs. As awareness grows, the Human Rabies Vaccine...0 Σχόλια 0 Μοιράστηκε 208 Views 0 Προεπισκόπηση
-
Killed virus vaccines still rule, but recombinant is the futureThe classic rabies vaccine is made from killed virus — it's safe, effective, and has decades of data. The human rabies vaccine market research shows that killed virus vaccines hold 59% market share. But they're not perfect: they require cold chain storage and can cause local reactions. Enter recombinant vaccines, which use only a single rabies protein. They're easier to...0 Σχόλια 0 Μοιράστηκε 60 Views 0 Προεπισκόπηση
-
You get bit by a stray dog — now what? The race against rabiesRabies is almost 100% fatal once symptoms appear. But it's also 100% preventable with prompt vaccination. The human rabies vaccine market report by MRFR shows that post‑exposure prophylaxis (PEP) accounts for 67% of vaccine use, because every year, millions of people are bitten by suspect animals. The market is $624 million and growing at 7% CAGR, driven by rising dog populations...0 Σχόλια 0 Μοιράστηκε 47 Views 0 Προεπισκόπηση
Προωθημένο
Προωθημένο